Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Dexamethasone With or Without Oblimersen in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00017602. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Somatostatin Receptors Imaging in Relapsing and Refractory Multiple Myeloma Patients
ClinicalTrials.gov study NCT04379817. IPD Sharing: NO. Countries: 1. Publications: 1.
A Phase 2 Study With Panzem in Patients With Relapsed or Plateau Phase Multiple Myeloma
ClinicalTrials.gov study NCT00592579. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Quality of Life in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00290095. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Preliminary Efficacy Study of the Antibody PAT-SM6 in Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01727778. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Chemokine Receptor CXCR4-targeting Molecular Imaging for Metabolic Characterization of Multiple Myeloma and Lymphoma
ClinicalTrials.gov study NCT03436342. IPD Sharing: NO. Countries: 1. Publications: 2.
VELCADE/Melphalan/Prednisone Versus Melphalan/Prednisone in Patients With Previously Untreated Multiple Myeloma
ClinicalTrials.gov study NCT00111319. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Study of Treatment for Newly Diagnosed Multiple Myeloma Patients Older Than 65 Years With Sequential Melphalan/Prednisone/Velcade (MPV) Followed by Revlimid/Low Dose Dexamethasone (Rd) Versus Alternat
ClinicalTrials.gov study NCT01237249. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Velcade-Melphalan-Prednisone in Older Untreated Multiple Myeloma Patients.
ClinicalTrials.gov study NCT00388635. IPD Sharing: Not stated. Countries: 1. Publications: 29.
A Study of CAR-T Cells Targeting GPRC5D in the Treatment of r/r Multiple Myeloma
ClinicalTrials.gov study NCT05016778. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Real World Insights During Treatment for Relapsed/Refractory Multiple Myeloma with Isatuximab
ClinicalTrials.gov study NCT05053607. IPD Sharing: NO. Countries: 1. Publications: 19.
Cancer Stem Cells in Multiple Myeloma
ClinicalTrials.gov study NCT01820546. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of KRN125 in Patients With Multiple Myeloma and Malignant Lymphoma
ClinicalTrials.gov study NCT05007652. IPD Sharing: NO. Countries: 1. Publications: 1.
Multiple Myeloma (MM) Profile in Brazil: A Retrospective Observational Analysis
ClinicalTrials.gov study NCT03506386. IPD Sharing: YES. Countries: 1. Publications: 0.
Belantamab Mafodotin and Lenalidomide for the Treatment of Multiple Myeloma in Patients With Minimal Residual Disease Positive After Stem Cell Transplant
ClinicalTrials.gov study NCT04876248. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Multiparametric Imaging in Multiple Myeloma
ClinicalTrials.gov study NCT02646085. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Efficacy Assessments of Osalmid in Multiple Myeloma
ClinicalTrials.gov study NCT03670173. IPD Sharing: NO. Countries: 1. Publications: 12.
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04634552. IPD Sharing: YES. Countries: 11. Publications: 8.
A Multicenter Open Label Phase II Study of Pomalidomide and Cyclophosphamide and Dexamethasone in Relapse/Refractory Multiple Myeloma Patients Who Were First Treated Within the IFM/DFCI 2009 Trial (PC
ClinicalTrials.gov study NCT02244125. IPD Sharing: NO. Countries: 1. Publications: 2.
Prognostic Potential of Cell Surface Markers and Pim Kinases in Multiple Myeloma
ClinicalTrials.gov study NCT01410981. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.